Shaemus Gleason Appointed Executive Vice President US Operations at Clarity Pharmaceuticals
Shaemus Gleason Appointed Executive Vice President US Operations at Clarity Pharmaceuticals News provided by Share this article Share this article SYDNEY, May 11, 2021 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce the appointment of Shaemus Gleason as Executive Vice President U.S. Operations as the company expands its presence, clinical trials, and operations in the U.S. Shaemus joins Clarity from Bayer's Oncology Strategic Business Unit where he has been employed since 2018, most recen...